Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Pharmacological Ascorbic Acid Suppresses Syngeneic Tumor Growth and Metastases in Hormone-refractory Prostate Cancer

HARVEY B. POLLARD, MARK A. LEVINE, OFER EIDELMAN and MORRIS POLLARD
In Vivo May 2010, 24 (3) 249-255;
HARVEY B. POLLARD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: hpollard@usuhs.mil
MARK A. LEVINE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
OFER EIDELMAN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MORRIS POLLARD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Images of primary PAIII tumor, axillary lymph node, and lung metastases in LW rat. a: Gross image of LW rat implanted with PAIII tumor cells. Primary PAIII tumor (labeled arrow) is shown for a control rat inoculated with 106 tumor cells. An enlarged, ipsilateral axillary lymph node is shown (see labeled arrow). Sub-pleural metastases are shown (see labeled thin arrow). b: Sub-pleural lung metastases. Lung metastases are grossly shown on rat lung surface. Large and small metastases are seen. The data in this paper are based on total sub-pleural metastases observed using ×5 magnification.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Influence of ascorbate on primary tumor weight and number of lung metastases. a: Influence of ascorbate treatment on primary tumor weight. Fifteen LW rats were treated with 106 PAIII cells, as described. Fifteen other rats were inoculated with the same number of PAIII cells, but also treated with ascorbate (4 g/kg), as described. After 40 days, rats were sacrificed and primary tumors dissected out for measurement of weight. The difference in weight between treated and untreated rats is significant (*p=0.026). b: Influence of ascorbate treatment on number of lung metastases. Lungs from the animals analyzed in Part a were fixed in Bouin's Fixative, and the total number of metastases counted. The difference in numbers of lung metastases in the two conditions is significant (#p=0.009).

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Receiver operating condition (ROC) curves for ascorbate effects on primary tumor weight and number of lung metastases. a: ROC curve for ascorbate effects on primary tumor weight. Area under the curve (AUC) is 0.75. A perfect discriminating cut-off point would have a value of 1.0. b: ROC curve for ascorbate effects on the number of lung metastases. Area under the curve (AUC) is 0.74. A perfect discriminating cut-off point would have a value of 1.0.

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    Ascorbate effects on the relationship between primary tumor weight and number of lung metastases. Data relating tumor weight to metastatic number in the absence of ascorbate treatment are shown in solid diamonds. The R2 value is only ~0.04, indicating essentially random distribution. Data relating tumor weight to metastatic number in the presence of ascorbate treatment are shown in solid squares. The R2 value is ca. 0.5, indicating a somewhat linear relationship. The vertical intercept is ca. −4.7, indicating a discrete lag between primary tumor weight and metastatic number.

Tables

  • Figures
  • Table I.
  • Table II.
PreviousNext
Back to top

In this issue

In Vivo
Vol. 24, Issue 3
May-June 2010
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on In Vivo.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Pharmacological Ascorbic Acid Suppresses Syngeneic Tumor Growth and Metastases in Hormone-refractory Prostate Cancer
(Your Name) has sent you a message from In Vivo
(Your Name) thought you would like to see the In Vivo web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
5 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Pharmacological Ascorbic Acid Suppresses Syngeneic Tumor Growth and Metastases in Hormone-refractory Prostate Cancer
HARVEY B. POLLARD, MARK A. LEVINE, OFER EIDELMAN, MORRIS POLLARD
In Vivo May 2010, 24 (3) 249-255;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Pharmacological Ascorbic Acid Suppresses Syngeneic Tumor Growth and Metastases in Hormone-refractory Prostate Cancer
HARVEY B. POLLARD, MARK A. LEVINE, OFER EIDELMAN, MORRIS POLLARD
In Vivo May 2010, 24 (3) 249-255;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • High-Dose Parenteral Ascorbate Enhanced Chemosensitivity of Ovarian Cancer and Reduced Toxicity of Chemotherapy
  • Beckwith-Wiedemann Syndrome: Potassium Ascorbate with Ribose Therapy in a Syndrome with High Neoplastic Risk
  • Intravenous Vitamin C Administration Improves Quality of Life in Breast Cancer Patients during Chemo-/Radiotherapy and Aftercare: Results of a Retrospective, Multicentre, Epidemiological Cohort Study in Germany
  • Vitamin C: A Concentration-Function Approach Yields Pharmacology and Therapeutic Discoveries
  • Google Scholar

More in this TOC Section

  • Orthotopic Mouse Models of Urinary Bladder Cancer
  • Effects of Chitosan on Chondrocytes Derived from Human Nasal Septal Cartilage
  • Humanized PD-1 Knock-in Mice Reveal Nivolumab’s Inhibitory Effects on Glioblastoma Tumor Progression In Vivo
Show more Experimental Studies

Similar Articles

In Vivo

© 2023 In Vivo

Powered by HighWire